BackAxa Overview

Axa EBIT

Track Axa's EBIT ($-5.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$0.00

As of Dec 31, 2025

Annual EBIT (TTM)

-$5.60B
216.45% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Axa (AXAHY) FAQ

As of the most recent data (December 2025), AXAHY shows a EBIT of $-5.6B. That compares with $4.8B in the prior-year period — down 216.5% year over year. That is below the Finance sector average of $300B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AXAHY's EBIT is now $-5.6B (was $4.8B) — a 216.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Axa is outperforming or lagging.

The Finance sector average EBIT is about $300B. Axa is at $-5.6B, which is lower that average. That is roughly 101.9% below the sector mean. Use the comparison chart on this page to see how AXAHY stacks up against individual peers as well.

Tracking AXAHY's ebit over time shows whether Axa is scaling, shrinking, or reshaping that part of the business. The current reading is $-5.6B That compares with $4.8B in the prior-year period — down 216.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Axa's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-5.6B) with ownership activity and broader fundamentals.